IC
AXSM icon

IEQ Capital’s Axsome Therapeutics AXSM Stock Holding History

IEQ Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Sell
7,730
-1,105
-13% -$240K 0.01% 822
2026
Q1 		$1.49M Sell
8,835
-560
-6% -$96.7K 0.01% 884
2025
Q4 		$1.72M Sell
9,395
-1,425
-13% -$199K 0.01% 846
2025
Q3 		$1.31M Buy
10,820
+2,972
+38% +$335K ﹤0.01% 911
2025
Q2 		$819K Buy
7,848
+3,032
+63% +$321K 0.01% 931
2025
Q1 		$562K Buy
+4,816
New +$549K ﹤0.01% 931

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IEQ Capital's AXSM Position: Q2 2026 in Review

IEQ Capital reduced its Axsome Therapeutics (AXSM) stake by 13% in Q2 2026, selling an estimated $240K and leaving 7,730 shares worth $1.89M. The position accounts for 0.01% of the portfolio, ranked #822.

IEQ Capital first reported a position in AXSM in Q1 2025 and has held it in 6 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • IEQ Capital held 7,730 shares of Axsome Therapeutics worth $1.89M as of Q2 2026.
  • IEQ Capital sold 1,105 Axsome Therapeutics shares in Q2 2026, an estimated $240K.
  • Axsome Therapeutics made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #822 holding.
  • IEQ Capital first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.